ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Evaluation of Zero-Exchange Transseptal Puncture Devices on Procedural Workflow and Consistency During Left Atrial Appendage Closure.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reducing the number of device exchanges during a left atrial appendage (LAA) closure procedure can minimize the risk of injury, air embolism, and thrombus, and optimize procedural workflow. This study compared zero-exchange transseptal puncture (TSP) workflows facilitated by VersaCross Connect (VCC) that integrate directly into WATCHMAN (WM) therapy sheaths (FXD Curve Access [FXD] and TruSteer), with other TSP devices. Methods: Retrospective chart analysis was performed comparing a radiofrequency needle TSP device, requiring multiple exchanges (NRG, n = 30), requiring at least 1 exchange (VersaCross Large Access, n = 49), to a zero-exchange workflow with VCC paired with WM FXD (VCC-FXD, n = 215), or TruSteer Access (TS) (VCC-TS, n = 78) in terms of time to TSP from procedure start and time to initial WM deployment post-TSP in LAA. Results: One hundred percent TSP success was achieved in all attempts (n = 372). One reported in-hospital death occurred (1/372, 0.27%, reported as not related to TSP). TSP was similar in all groups. Time to initial WM deployment was significantly improved with zero-exchange devices, as was consistency between cases. Subanalysis of the 2 therapy sheaths integrated to VCC performed similarly in time to TSP time, and to initial WM deployment (VCC-FXD = 8.0 ± 4.0 minutes, VCC-TS = 8.1 ± 4.5; Conclusions: Use of VCC, providing a zero-exchange solution for LAA closure, resulted in an improved workflow and consistency of the first deployment of the WM device in LAA. Integration with FXD or TruSteer sheaths resulted in similar improvements overall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.